Open Access

Poster Session 1 - Basic Science: Co-morbidities

Event: HEART FAILURE 2016
Topic: Miscellaneous
Session type: Poster Session
Date: 21 May 2016

Session

5 presentations in this session

Enalapril, eplerenone or their combination: finding the best paradigm to protect against Doxorubicin-Induced Cardiotoxicity

Speaker: Professor R. Hullin (Lausanne, CH)
Thumbnail

Ranolazine protects from trastuzumab cardiomyopathy

Speaker: Doctor N. Maurea (Naples, IT)
Thumbnail

Sildenafil treatment in a rat model of cancer cachexia

Speaker: Doctor S. Nucera (Catanzaro, IT)
Thumbnail

Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity in vitro and in vivo

Speaker: Professor W. Kim (Seoul, KR)
Thumbnail

TLR4 and TLR2 detection method from peripheral human blood for early detection of doxorubicin induced cardiotoxicity

Speaker: Assistant Professor M. Trofenciuc (Arad, RO)
Thumbnail

5 speakers from this session

Professor Roger Hullin

CHUV and Faculty of Biology and Medicine, Department of Medicine, Internal Medicine, Lausanne (Switzerland)
1 presentation
0 follower

Doctor Nicola Maurea

National Cancer Institute G. Pascale, Naples (Italy)
2 presentations
1 follower

Doctor Saverio Nucera

Magna Graecia University of Catanzaro, Catanzaro (Italy)
0 follower

Professor Weon Kim

Kyung Hee University Hospital, Seoul (Korea (Republic of))
0 follower

Assistant Professor Mihai-Nelu Trofenciuc

Vasile Goldis Western University, Arad (Romania)
1 presentation
1 follower

This platform is supported by

logo Novo Nordisk